Valerie D Callender1, Andrew F Alexis2, Selena R Daniels3, Ariane K Kawata4, Caroline T Burk5, Teresa K Wilcox4, Susan C Taylor6. 1. Callender Dermatology & Cosmetic Center, Glenn Dale, Maryland; 2. Skin of Color Center, Department of Dermatology, St. Luke's-Roosevelt Hospital Center, New York, New York; 3. Allergan, Inc., Irvine, California; 4. Evidera, Bethesda, Maryland; 5. Health Outcomes Consultant, Laguna Beach, California; 6. Society Hill Dermatology, Philadelphia, Pennsylvania.
Abstract
OBJECTIVE: Limited data are available on racial differences in clinical characteristics and burden in adult female acne. The objective was to describe racial differences in clinical characteristics, psychosocial impact, perceptions, behaviors, and treatment satisfaction in facial adult female acne. DESIGN: Cross-sectional, web-based survey. SETTING: Diverse sample of United States women. PARTICIPANTS: Women between the ages of 25 and 45 years with facial acne (≥25 visible lesions). MEASUREMENTS: Outcomes included sociodemographic characteristics, psychosocial impacts, perceptions, behaviors, and treatment satisfaction. Racial differences were evaluated using descriptive statistics and t-test/chi-square analyses. RESULTS: 208 females participated (mean age 35±6 years); 51.4 percent were White/Caucasian and 48.6 percent were non-White/Caucasian women [Black/African American (n=51); Hispanic/Latina (n=23); Asian (n=16); Other (n=ll)]. Age of acne onset (mean 14.8±5 vs. 17.0±8 years, p<0.05) and acne concern occurred earlier (16.6±7 vs. 19.3±9 years, p<0.05) in White/Caucasian than non-White/Caucasian subjects. Facial acne primarily presented on chin (28.0%) and cheeks (30.8%) for White/Caucasian women versus cheeks (58.4%) for non-White/Caucasian women. Non-White/Caucasian women experienced more postinflammatory hyperpigmentation than White/Caucasian women (p<0.0001). Facial acne negatively affected quality of life (QoL) in both groups, and most participants (>70%) reported some depression/anxiety symptoms. More White/Caucasian than non-White/Caucasian women were troubled by facial acne (88.8% vs. 76.2%, p<0.05). Lesion clearance was most important to White/Caucasian women (57.9 vs. non-White/Caucasian 31.7%, p<0.001); non-White/Caucasian females focused on postinflammatory hyperpigmentation clearance (41.6% vs. Caucasian 8.4%, p<0.0001). CONCLUSION: RESULTS highlight racial differences in participant-reported clinical characteristics, attitudes, behaviors, and treatment satisfaction. These findings may inform clinicians about racial differences in facial adult female acne and guide treatment recommendations toward improving care.
OBJECTIVE: Limited data are available on racial differences in clinical characteristics and burden in adult female acne. The objective was to describe racial differences in clinical characteristics, psychosocial impact, perceptions, behaviors, and treatment satisfaction in facial adult female acne. DESIGN: Cross-sectional, web-based survey. SETTING: Diverse sample of United States women. PARTICIPANTS: Women between the ages of 25 and 45 years with facial acne (≥25 visible lesions). MEASUREMENTS: Outcomes included sociodemographic characteristics, psychosocial impacts, perceptions, behaviors, and treatment satisfaction. Racial differences were evaluated using descriptive statistics and t-test/chi-square analyses. RESULTS: 208 females participated (mean age 35±6 years); 51.4 percent were White/Caucasian and 48.6 percent were non-White/Caucasian women [Black/African American (n=51); Hispanic/Latina (n=23); Asian (n=16); Other (n=ll)]. Age of acne onset (mean 14.8±5 vs. 17.0±8 years, p<0.05) and acne concern occurred earlier (16.6±7 vs. 19.3±9 years, p<0.05) in White/Caucasian than non-White/Caucasian subjects. Facial acne primarily presented on chin (28.0%) and cheeks (30.8%) for White/Caucasian women versus cheeks (58.4%) for non-White/Caucasian women. Non-White/Caucasian women experienced more postinflammatory hyperpigmentation than White/Caucasian women (p<0.0001). Facial acne negatively affected quality of life (QoL) in both groups, and most participants (>70%) reported some depression/anxiety symptoms. More White/Caucasian than non-White/Caucasian women were troubled by facial acne (88.8% vs. 76.2%, p<0.05). Lesion clearance was most important to White/Caucasian women (57.9 vs. non-White/Caucasian 31.7%, p<0.001); non-White/Caucasian females focused on postinflammatory hyperpigmentation clearance (41.6% vs. Caucasian 8.4%, p<0.0001). CONCLUSION: RESULTS highlight racial differences in participant-reported clinical characteristics, attitudes, behaviors, and treatment satisfaction. These findings may inform clinicians about racial differences in facial adult female acne and guide treatment recommendations toward improving care.
Authors: Krista A Payne; Sepideh F Varon; Ariane K Kawata; Karen Yeomans; Teresa K Wilcox; Aubrey Manack; Dawn C Buse; Richard B Lipton; Peter J Goadsby; Andrew M Blumenfeld Journal: Cephalalgia Date: 2011-06-20 Impact factor: 6.292
Authors: Joe Gorelick; Selena R Daniels; Ariane K Kawata; Arnold Degboe; Teresa K Wilcox; Caroline T Burk; Tracee Douse-Dean Journal: J Dermatol Nurses Assoc Date: 2015-05
Authors: Marta I Rendon; David A Rodriguez; Ariane K Kawata; Arnold N Degboe; Teresa K Wilcox; Caroline T Burk; Selena R Daniels; Wendy E Roberts Journal: Clin Cosmet Investig Dermatol Date: 2015-05-02